Current Investments

Adapsyn Bioscience Inc.http://www.adapsyn.comAdapsyn Bioscience Inc. Logo

Adapsyn Bioscience Inc. is a biotechnology company focused on the discovery and development of novel medicines derived from evolved small molecule natural products. The company applies proprietary algorithms and artificial intelligence to genomic and metabolomic data from microbes to find novel natural product drug candidates.

Aptinyxhttp://www.aptinyx.comAptinyx

Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication.

Fairhaven Pharmaceuticals Inc.

Fairhaven is a pharmaceutical company focused on developing novel, small molecule, oral therapeutics for severe inflammatory conditions.

Flosonics Medicalhttp://www.flosonicsmedical.comFlosonics Medical logo

Flosonics is a medical device company focused on developing non-invasive sensors to improve the management of critically ill patients. Flosonics Medical’s flagship smart-bandage product, the FloPatch, addresses unmet clinical needs of critically ill patients and the physicians, nurses, and paramedics who care for them in the ambulance, emergency department, operating room, and intensive care unit.

Functional Neuromodulation Ltd.http://www.fxneuromod.comFunctional Neuromodulation Ltd. logo

Functional Neuromodulation Ltd. is a start-up medical technology company focused on advancing innovative neuromodulation technologies for the treatment of cognitive and memory disorders.

Fusionhttp://www.fusionpharma.comFusion Pharmaceuticals

Fusion Pharmaceuticals is a targeted radioimmunotherapeutics company focused in creating novel alpha emitting therapeutics for cancer.

Impopharmahttp://www.impopharma.comImpopharma logo

Impopharma Inc. is a pharmaceutical company focused on the development of nasal and pulmonary products.

Inversago Pharmahttps://inversago.comInversago Pharma

A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome (PWS), Type-1 Diabetes (T1D), obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH). Inversago’s technology addresses limits associated with first generation CB1 blockers, allowing the company to exploit their full medical potential.

Invitae Corporationhttp://invitae.comInvitae Corporation logo

Invitae Corporation is a company focused on commercial applications of next generation sequencing. The company is applying advances in genomics to provide more comprehensive, less costly, higher quality clinical genetic solutions for patient, providers and payer alike.

Profound Medical Inc.http://www.profoundmedical.comProfound Medical Inc. logo

Profound Medical Inc., founded in June 2008, is a privately-held medical device company dedicated to developing a novel treatment for Prostate Cancer; delivering the fastest, least-invasive, and highest Quality-of-Life outcomes for patients of the disease.

Therapeutic Monitoring Systemshttp://www.therapeuticmonitoring.comTherapeutic Monitoring Systems logo

Therapeutic Monitoring Systems is a software development company.  Its CIMVA software platform holds the promise of greatly enhancing patient care while saving the healthcare system significant costs associated with clinical uncertainty.

Tioga Pharmaceuticals, Inc.http://www.tiogapharma.com/Tioga Pharmaceuticals, Inc. logo

Tioga Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of pruritus.  Tioga's lead compound, asimadoline, is in a Phase 2 study in patients with pruritus due to atopic dermatitis.